Target Hospitality Corp

TH

NASDAQ. Currency in USD

15.48 +0.54 ( +3.65% )

Real time prices: December 05

Market Cap.
1.51B
Beta (5Y monthly)
2.75
Price/Earnings
29.06
EPS (TTM)
0.48
Forward Dividend
0.00 (0.00%)
Ex-Dividend Date
Volume
2.26M
1y Target Est.
20.67
Day's Range
14.83
-
16.05
52 Week's Range
2.72
-
16.05

Historical Summary

Performance
EPS growth
Share Buybacks

About Target Hospitality Corp

Sector
Energy
Industry
Oil & Gas Equipment & Services
Website
https://www.targethospitality.com
Exchange
NASDAQ (XNAS)
Shares Outstanding
101.84M
Employees
823
Address
9320 Lakeside Boulevard, The Woodlands, TX, United States, 77381
Target Hospitality Corp. operates as a specialty rental and hospitality services company in North America. The company operates through four segments: Hospitality & Facilities Services - South, Hospitality & Facilities Services - Midwest, Government, and TCPL Keystone. It owns a network of specialty rental accommodation units with approximately 15,528 beds across 27 communities, which include 26 owned and 1 leased; and operates 1 community not owned or leased by the company. Target Hospitality Corp. also provides catering and food, maintenance, housekeeping, grounds-keeping, security, health and recreation, workforce community management, concierge, and laundry services. It serves the U.S. government, government contractors, investment grade natural resource development companies, and energy infrastructure companies. The company was founded in 1978 and is headquartered in The Woodlands, Texas.

Latest news

Activision (ATVI) Q3 Earnings, Revenues Fall Y/Y on Soft Demand
Activision (ATVI) Q3 Earnings, Revenues Fall Y/Y on Soft Demand

Activision Blizzard's (ATVI) third-quarter 2022 results reflect a negative impact from lower PC and console...
By Zacks Investment Research - 3 weeks ago

Theratechnologies présente des données révélant une surexpression de la sortiline 1 (SORT1) dans plusieurs types de tumeurs solides évaluée à partir de micromatrices tissulaires
Theratechnologies présente des données révélant une surexpression de la sortiline 1 (SORT1) dans plusieurs types de tumeurs solides évaluée à partir de micromatrices tissulaires

MONTRÉAL, 26 oct. 2022 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (« Theratechnologies » ou « la...
By GlobeNewswire Inc. - 5 weeks ago

Theratechnologies Reports Data Showing High Expression of Sortilin (SORT1) in Multiple Solid Tumors from Tissue Microarrays
Theratechnologies Reports Data Showing High Expression of Sortilin (SORT1) in Multiple Solid Tumors from Tissue Microarrays

MONTREAL, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH)...
By GlobeNewswire Inc. - 5 weeks ago

Is Swedish Match (SWMAY) Outperforming Other Consumer Discretionary Stocks This Year?
Is Swedish Match (SWMAY) Outperforming Other Consumer Discretionary Stocks This Year?

Here is how Swedish Match AB Unsponsored ADR (SWMAY) and Target Hospitality (TH) have performed...
By Zacks Investment Research - 6 weeks ago

Theratechnologies présente ses résultats financiers pour le troisième trimestre de l’exercice 2022 et une mise à jour concernant ses activités commerciales
Theratechnologies présente ses résultats financiers pour le troisième trimestre de l’exercice 2022 et une mise à jour concernant ses activités commerciales

- Hausse de 17 % des revenus consolidés au troisième trimestre de 2022, pour atteindre...
By GlobeNewswire Inc. - 7 weeks ago

Theratechnologies Reports Financial Results for the Third Quarter of Fiscal 2022 and Provides Business Update
Theratechnologies Reports Financial Results for the Third Quarter of Fiscal 2022 and Provides Business Update

- Q3 2022 Consolidated Revenue Growth of 17% to $20.8 million
By GlobeNewswire Inc. - 7 weeks ago

Theratechnologies présente des données démontrant la surexpression de la sortiline (SORT1) dans plusieurs types de tumeurs au 34e symposium de l’EORTC-NCI-AACR
Theratechnologies présente des données démontrant la surexpression de la sortiline (SORT1) dans plusieurs types de tumeurs au 34e symposium de l’EORTC-NCI-AACR

MONTRÉAL, 12 oct. 2022 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (« Theratechnologies » ou « la...
By GlobeNewswire Inc. - 7 weeks ago

Theratechnologies Presents Data Demonstrating High Expression of Sortilin (SORT1) in Multiple Tumor Types at 34th EORTC-NCI-AACR Symposium
Theratechnologies Presents Data Demonstrating High Expression of Sortilin (SORT1) in Multiple Tumor Types at 34th EORTC-NCI-AACR Symposium

MONTREAL, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH)...
By GlobeNewswire Inc. - 7 weeks ago